risk assessment ii
DESCRIPTION
Risk Assessment II. Dec 9, 2009. For effects other than cancer:. Is there a “safe” dose ?. Dose-Response. Increasing Response. 0. Dose. Threshold. Non-carcinogens N o O bserved A dverse E ffects L evel NOAEL. ACCEPTABLE DAILY INTAKE (ADI) or TOLERABLE DAILY INTAKE (TDI) - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/1.jpg)
Risk Assessment II
Dec 9, 2009
![Page 2: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/2.jpg)
Is there a “safe” dose ?
For effects other than cancer:
![Page 3: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/3.jpg)
Dose-Response
Dose
Increasing Response
0Threshold
![Page 4: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/4.jpg)
Non-carcinogensNo
Observed
Adverse
Effects
Level
NOAEL
![Page 5: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/5.jpg)
ACCEPTABLE DAILY INTAKE (ADI) or TOLERABLE DAILY INTAKE (TDI)
The amount of a substance that can be ingested over a lifetime without significant health risk
ADI = NOAEL Safety Factor(s)
Poor quality of data
Safety Factor = 10 x 10 [x 10] [x 10]Inter-speciesAnimal-to-human Intra-species Particularly
inter-individual severe effectvariability
Units: mg/kg/dayBased on most sensitive species and most sensitive end-point
![Page 6: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/6.jpg)
Extrapolations
• From short-term studies to lifetime exposure
• From high doses in animal studies to low doses in environmental exposure
• From animals to humans
![Page 7: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/7.jpg)
Scale from animal to human
• Scale according to body weight (BW)• Scale according to surface area – (BW)2/3
• Scale according to relative metabolic rates – (BW)3/4
• Biological modeling – physiologically-based (PBPK)
![Page 8: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/8.jpg)
Variability • Inter-individual
variation in – Exposure– Metabolism– Repair capacity– Sensitivity– …
Uncertainty: Factors that we do not know or understand fully (yet)
• True magnitude of– Exposure– Metabolism– Repair capacity– Sensitivity
• How to extrapolate from test animals to humans, high to low doses…
• How to combine risks
![Page 9: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/9.jpg)
Carcinogens: There exists a “measurable” risk from any exposure,
eg 4.1 x 10 -6 cancer risk for exposure to 1 μg/m3 of CH2Cl2 for a lifetime
Non-carcinogens: A “safe” dose can be determined
Pathogens: An “infectious dose” can be determined- ID50, , - Dose that produces 1 in 104 risk of infection
Each is considered in isolation
Approach has been chemical by chemical.Multiple chemical exposure requires combined risk assessment approach. Multiple sources of exposure need to be accounted for.
![Page 10: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/10.jpg)
Combinations
• Binary mixtures• Ternary mixtures• Four- , five-component mixtures• Six, seven, eight….• ...• Complex mixtures
![Page 11: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/11.jpg)
The Risk Cup• Food Quality Protection Act (1996)
– Amendment to Food Drugs and Cosmetics Act (1906, 1938)
• “Assess the risk of the pesticide chemical residue [to infants and children] based on…available information concerning the cumulative effects on infants and children of such residues and other substances that have a common mechanism of toxicity”
![Page 12: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/12.jpg)
Interactions
• Additivity• Synergism• Potentiation• Antagonism
![Page 13: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/13.jpg)
Interactions can be expected between chemicals that
• Act by binding to the same receptor• Act through the same mechanism• Require the same enzyme for
activation/detoxication
![Page 14: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/14.jpg)
Additivity
• Chemicals A, B, C…N are all toxic• Potency of mixture = Sum of potencies *
concentrations of constituents
• Effecttotal = PotencyA * DoseA + PotencyB * DoseB + PotencyC * DoseC +…..+PotencyN * DoseN
![Page 15: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/15.jpg)
Synergism
• The whole is greater than the sum of the individual constituents
Effecttotal >> PotencyA* DoseA + PotencyB* DoseB… +… + PotencyN* DoseN
![Page 16: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/16.jpg)
Potentiation
• One constituent A is toxic, the other B is not.
• Effect of the combination A + B is greater than the effect of the active constituent
Effecttotal >> PotencyA* DoseA
where PotencyB = 0
![Page 17: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/17.jpg)
Antagonism
• Effect of the whole is less than the sum of the effects of the individual components
Effecttotal << PotencyA* DoseA + PotencyB* DoseB… +… + PotencyN* DoseN
![Page 18: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/18.jpg)
![Page 19: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/19.jpg)
• Competing risks
Drinking water disinfectant by-products
↔ infectious diseases
![Page 20: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/20.jpg)
Comparison of RisksDisabilityAdjustedLifeYears
One DALY = 1 lost year of healthy lifeDisability is weighted by a factor that reflects the severity of the disease on a scale from 0 (perfect health) to 1 (equivalent to death). WHO Global Burden of Disease analysis http://www.who.int/healthinfo/global_burden_disease/en/index.html
![Page 21: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/21.jpg)
![Page 22: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/22.jpg)
Some examples of weighing factors
• Asthma -- 0.043• Blindness – 0.600• Cancer: Liver – 0.20• Cancer: Trachea, bronchus and lung 0.15
– Metastatic 0.75• Cirrhosis of the liver - 0.330• Cleft palate - Cases 0.103• Diarrheal diseases - 0.105• Malaria - 0.191
![Page 23: Risk Assessment II](https://reader036.vdocuments.site/reader036/viewer/2022070504/5681682e550346895dddcbab/html5/thumbnails/23.jpg)
USA, Both sexes, National Center for Health Statistics
Life expectancy at birth
Year of birth
Age at death
Year of birth
Age at death
1900 47.3 1980 73.71950 68.2 1990 75.4
1960 69.7 2000 77.0
1970 70.8 2005 77.82007 77.9